112 related articles for article (PubMed ID: 30664244)
1. Transformation of mature mouse B cells into malignant plasma cells in vitro via introduction of defined genetic elements.
Högstrand K; Lindvall JM; Sundblad A; Grandien A
Eur J Immunol; 2019 Mar; 49(3):454-461. PubMed ID: 30664244
[TBL] [Abstract][Full Text] [Related]
2. MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.
Högstrand K; Grandien A
Eur J Immunol; 2019 Mar; 49(3):375-385. PubMed ID: 30281155
[TBL] [Abstract][Full Text] [Related]
3. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.
Chung EY; Psathas JN; Yu D; Li Y; Weiss MJ; Thomas-Tikhonenko A
J Clin Invest; 2012 Jun; 122(6):2257-66. PubMed ID: 22546857
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor IRF4 regulates germinal center cell formation through a B cell-intrinsic mechanism.
Willis SN; Good-Jacobson KL; Curtis J; Light A; Tellier J; Shi W; Smyth GK; Tarlinton DM; Belz GT; Corcoran LM; Kallies A; Nutt SL
J Immunol; 2014 Apr; 192(7):3200-6. PubMed ID: 24591370
[TBL] [Abstract][Full Text] [Related]
5. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells.
Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Ohta S; Hirai Y; Kimoto M; Miyake K; Takatsu K
Int Immunol; 2012 Jun; 24(6):389-400. PubMed ID: 22354914
[TBL] [Abstract][Full Text] [Related]
6. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
7. Reversible expression of CD138 on mature follicular B cells is downregulated by IL-4.
Lee JG; Moon H; Park C; Shin SH; Kang K; Kim TJ
Immunol Lett; 2013; 156(1-2):38-45. PubMed ID: 24029663
[TBL] [Abstract][Full Text] [Related]
8. The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies.
Malaney P; Velasco-Estevez M; Aguilar-Garrido P; Aitken MJL; Chan LE; Zhang X; Post SM; Gallardo M
Front Immunol; 2021; 12():634584. PubMed ID: 33912162
[TBL] [Abstract][Full Text] [Related]
9. IRF4 addiction in multiple myeloma.
Shaffer AL; Emre NC; Lamy L; Ngo VN; Wright G; Xiao W; Powell J; Dave S; Yu X; Zhao H; Zeng Y; Chen B; Epstein J; Staudt LM
Nature; 2008 Jul; 454(7201):226-31. PubMed ID: 18568025
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.
Nakagawa M; Tsuzuki S; Honma K; Taguchi O; Seto M
Haematologica; 2011 Sep; 96(9):1318-26. PubMed ID: 21606168
[TBL] [Abstract][Full Text] [Related]
11. CpG oligodeoxynucleotides rescue BKS-2 immature B cell lymphoma from anti-IgM-mediated growth inhibition by up-regulation of egr-1.
Han SS; Chung ST; Robertson DA; Chelvarajan RL; Bondada S
Int Immunol; 1999 Jun; 11(6):871-9. PubMed ID: 10360960
[TBL] [Abstract][Full Text] [Related]
12. Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases.
Coupland SE; Hellmich M; Auw-Haedrich C; Lee WR; Anagnostopoulos I; Stein H
Br J Ophthalmol; 2005 Mar; 89(3):352-9. PubMed ID: 15722318
[TBL] [Abstract][Full Text] [Related]
13. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
[TBL] [Abstract][Full Text] [Related]
14. Generation of precursor, immature, and mature murine B1-cell lines from c-myc/bcl-xL-overexpressing pre-BI cells.
Wolf I; Bouquet C; Naumann F; Melchers F
Eur J Immunol; 2017 May; 47(5):911-920. PubMed ID: 28294314
[TBL] [Abstract][Full Text] [Related]
15. Interferon regulatory factor 4 and 8 in B-cell development.
Lu R
Trends Immunol; 2008 Oct; 29(10):487-92. PubMed ID: 18775669
[TBL] [Abstract][Full Text] [Related]
16. cDNA-library testing identifies transforming genes cooperating with c-myc in mouse pre-B cells.
Wolf I; Bouquet C; Melchers F
Eur J Immunol; 2016 Nov; 46(11):2555-2565. PubMed ID: 27538750
[TBL] [Abstract][Full Text] [Related]
17. Pim1 and Myc reversibly transform murine precursor B lymphocytes but not mature B lymphocytes.
Bouquet C; Melchers F
Eur J Immunol; 2012 Feb; 42(2):522-32. PubMed ID: 22101984
[TBL] [Abstract][Full Text] [Related]
18. MYC's Fine Line Between B Cell Development and Malignancy.
de Barrios O; Meler A; Parra M
Cells; 2020 Feb; 9(2):. PubMed ID: 32102485
[TBL] [Abstract][Full Text] [Related]
19. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation.
Sciammas R; Shaffer AL; Schatz JH; Zhao H; Staudt LM; Singh H
Immunity; 2006 Aug; 25(2):225-36. PubMed ID: 16919487
[TBL] [Abstract][Full Text] [Related]
20. CMTM7 plays key roles in TLR-induced plasma cell differentiation and p38 activation in murine B-1 B cells.
Liu Z; Liu Y; Li T; Wang P; Mo X; Lv P; Ma D; Han W
Eur J Immunol; 2020 Jun; 50(6):809-821. PubMed ID: 32022930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
